CPA’s submission, “Ensuring U.S. Sovereignty in North American Trade,” concludes that the current trilateral USMCA framework binds two vastly different economies to one unenforceable system—with each reliant on the far larger U.S. consumer market.
The report, titled “Section 232 Steel Tariffs are Necessary for National Security,” highlights how the Trump administration’s Section 232 tariffs have revitalized American manufacturing, created jobs, and strengthened national security.
KEY POINTS Beef prices are at record highs—not because of U.S. ranchers or tariffs, but because dependence on foreign imports and meatpacker consolidation have distorted
The report, titled “America’s Chip-for-Chip Tariff Policy: The Urgent Fight to Reclaim Industrial Independence Before It’s Too Late,” finds that the United States now produces only 10 percent of the world’s chips—and almost none of the most advanced ones—while China has captured the majority of global capacity for legacy chips, the mature semiconductors essential to cars, medical devices, and industrial equipment.
Titled “The New Biotech Cold War: The U.S. Medicine Can’t Afford to Fall Behind China,” the report shows how U.S. biotech – long a pillar of national strength – no longer has a guaranteed edge globally.
The U.S. Shipbuilding Base has Withered Since the 80s; Latest CPA Report Examines What’s Needed to Bring it Back
The August 2025 inflation report has reignited debate over tariffs. Some pundits have been quick to blame trade policy for rising prices, invoking Smoot-Hawley comparisons and warning of disaster on the scale of the Great Depression. But the data tells a different story.
Data centers powering AI need copper wiring and transformers. EVs use nearly four times more copper than gas-powered cars. Wind turbines, solar farms and the modern electric grid all depend on it. As such, copper is a building block of tomorrow’s economy and the backbone of America’s national security.
America is dangerously reliant on high-risk foreign suppliers for essential generic drugs, especially APIs concentrated in China and India. That over-reliance has already triggered preventable crises, such as nationwide chemotherapy shortages when a single overseas plant shut down.
The African Growth and Opportunity Act (AGOA), enacted in 2000, was designed to promote economic development and democratic reform in Sub-Saharan Africa by granting duty-free access to the U.S. market for thousands of products.
